Uniogen Oy

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Uniogen Oy - overview

Established

2022

Location

Turku, -, Finland

Primary Industry

Medical Devices & Equipment

About

Based in Turku, Finland, and founded in 2022, Uniogen Oy operates as a provider of clinical diagnostics, point-of-care testing, and instrumentation for life sciences. In January 2022, Abacus Diagnostica Oy and Labrox Oy, portfolio companies of Innovestor, and Kaivogen Oy merged to form Uniogen Oy. As of 2023, the company is led by its CEO, Ilari Antila. Uniogen offers various diagnosis solutions, including the GenomEra® CDX system used for the detection of various infectious agents, including SARS-CoV-2.


The company also provides various ready-to-use reagents, components, and individualized assay development services, including kit manufacturing, plate production, biomolecule conjugation, and buffer preparation. Following the January 2022 acquisition, the company plans to invest in R&D and sales, generate operational synergies, and expand the combined customer base.


Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Supplies, Medical Equipment Distributors, Diagnostic Equipment, Medical Software

Website

www.uniogen.com

Verticals

HealthTech, Manufacturing

Total Amount Raised

Subscriber access only

Uniogen Oy - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
MergerCompletedAbacus Diagnostica Oy, Kaivogen Oy, Labrox Oy-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.